As shown in Figure 7, we demonstrated that miR-1 suppressed aerobic glycolysis while Smad3 promoted it via its downstream effecter HIF-1α and glycolytic enzymes, including HK2, MCT4, in colorectal cancer. Here, SMAD3 is linked to colorectal cancer.